Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts.

Arriero Mdel M, Ramis JM, Perelló J, Monjo M.

PLoS One. 2012;7(8):e43187. doi: 10.1371/journal.pone.0043187. Epub 2012 Aug 14.

PMID:
22905230
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Undieh AS.

Pharmacol Ther. 2010 Oct;128(1):37-60. doi: 10.1016/j.pharmthera.2010.05.003. Epub 2010 Jun 12. Review.

PMID:
20547182
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Apoptotic effect of IP(6) was not enhanced by co-treatment with myo-inositol in prostate carcinoma PC3 cells.

Kim HJ, Jang YM, Kim H, Kwon YH.

Nutr Res Pract. 2007 Fall;1(3):195-9. doi: 10.4162/nrp.2007.1.3.195. Epub 2007 Sep 30.

PMID:
20368938
[PubMed]
Free PMC Article
4.

p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.

Roy S, Gu M, Ramasamy K, Singh RP, Agarwal C, Siriwardana S, Sclafani RA, Agarwal R.

Cancer Res. 2009 Feb 1;69(3):1166-73. doi: 10.1158/0008-5472.CAN-08-3115. Epub 2009 Jan 27.

PMID:
19176374
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk